Senior Advisor

Marshal Salomon currently serves as a Senior Advisor to The Oncology Institute and brings over 20 years of executive leadership experience in multi-site healthcare organizations to the role​. He joined The Oncology Institute as Chief Executive Officer and a member of the Board of Directors in January 2019. Mr. Salomon previously served as CEO of InterDent Service Corporation, one of the nation’s leading Dental Support Organizations, providing non-clinical support services to nearly 500 dentists across 200 affiliated dental offices including the management of over 300,000 capitated lives in the state of Oregon.

Mr. Salomon was previously the Chief Operating Officer of Vantage Oncology (Vantage), a provider of high quality, community-based cancer care through 50 treatment facilities in 13 states in conjunction with more than 200 physician partners and affiliates. Vantage’s mission was to address the growing need among cancer patients, hospitals and physicians for accessible and advanced cancer treatments. As COO, he oversaw Vantage’s nationwide network and was instrumental to the company’s culture, infrastructure development and prosperous growth. Prior to his role as COO, Mr. Salomon served as Vantage’s CFO. In 2016, McKesson Corp. acquired Vantage Oncology in a successful outcome for Vantage’s employees, physicians and investors.

Prior to Vantage, Mr. Salomon spent more than five years as a senior executive at DaVita, Inc. (NYSE: DVA), a leading provider of dialysis services. Mr. Salomon graduated from Brown University with a Bachelor’s degree in Economics and earned a Master’s degree in Business Administration from The Anderson School at UCLA.

11480 Brookshire Ave #309
United States